Haibin Zhou

Haibin Zhou

University of Michigan

H-index: 20

North America-United States

About Haibin Zhou

Haibin Zhou, With an exceptional h-index of 20 and a recent h-index of 17 (since 2020), a distinguished researcher at University of Michigan, specializes in the field of Medicinal Chemistry, Organic Synthesis, Targeted Drug Discovery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Evaluation of a highly potent and selective STAT3 degrader as a new class of immunotherapy

Discovery of highly potent, selective and efficacious STAT3 PROTAC degraders capable of achieving complete tumor regression

Small molecule stat protein degraders

Method of treating graft-versus-host disease

STAT3 restrains dendritic cell function and tumor immunity

Small molecule degraders of stat3

Stat3 protein degraders

Small molecule menin inhibitors

Haibin Zhou Information

University

Position

___

Citations(all)

1742

Citations(since 2020)

1133

Cited By

1006

hIndex(all)

20

hIndex(since 2020)

17

i10Index(all)

24

i10Index(since 2020)

19

Email

University Profile Page

Google Scholar

Haibin Zhou Skills & Research Interests

Medicinal Chemistry

Organic Synthesis

Targeted Drug Discovery

Top articles of Haibin Zhou

Evaluation of a highly potent and selective STAT3 degrader as a new class of immunotherapy

Cancer Research

2024/3/22

Discovery of highly potent, selective and efficacious STAT3 PROTAC degraders capable of achieving complete tumor regression

Cancer Research

2024/3/22

Small molecule stat protein degraders

2023/5/25

Method of treating graft-versus-host disease

2023/5/4

STAT3 restrains dendritic cell function and tumor immunity

The Journal of Immunology

2023/5/1

Small molecule degraders of stat3

2023/3/16

Stat3 protein degraders

2022/6/16

Small molecule menin inhibitors

2021/11/18

Removal notice to" Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells"[YEXCR Volume 315, Issue …

Experimental cell research

2021/7/1

Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity

Nature Communications

2021/5/11

SD-91 as a potent and selective STAT3 degrader capable of achieving complete and long-lasting tumor regression

ACS Medicinal Chemistry Letters

2021/5/10

Discovery of potent small-molecule inhibitors of MLL methyltransferase

ACS Medicinal Chemistry Letters

2020/5/14

Targeting DCN1-UBC12 protein-protein interaction for regulation of neddylation pathway

2020

See List of Professors in Haibin Zhou University(University of Michigan)